PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE

por Bouchakor Moussa, Y., Taoussi, S., Oukid, S., Lamraoui, F., Rekab, N., Benlabiod, K. M., Brahimi, H., Abad, M. T., Bradai, M.
Publicado 2022

EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic

por Tebaibia, A, Mammeri, A, Brahimi, H, Ammi, M, AitSaid, N, Lebdjiri, M, Grine, S, Tagzout, D, Hadjene, L, Bradaia, H, Hamrour, F, Hocine, O, Hamouni, M, Toudji, N, Aouadi, M, Khedairia, I, Djafour, W, Bouriah, A, Belkadi, A, Bouabana, F
Publicado 2022

EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008...

por Tebaibia, A, Mammeri, A, Brahimi, H, Ammi, M, AitSaid, N, Lebdjiri, M, Grine, S, Tagzout, D, Hadjene, L, Bradaia, H, Hamrour, F, Hocine, O, Hamouni, M, Toudji, N, Aouadi, M, Khedairia, I, Djafour, W, Bouriah, A, Belkadi, A, Bouabana, F
Publicado 2022